Skip to content

Optical Coherence Tomography in the Diagnosis of Scleritis and Episcleritis

Optical Coherence Tomography in the Diagnosis of Scleritis and Episcleritis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01958567
Enrollment
32
Registered
2013-10-09
Start date
2012-07-31
Completion date
2014-04-30
Last updated
2014-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Scleritis and Episcleritis

Keywords

Scleritis, Episcleritis, Optical coherence Tomography

Brief summary

The main purpose of this study is to describe the optical coherence tomography (OCT) findings in eyes with scleral inflammation and to differentiate cases with anterior scleritis from those with episcleritis and normal controls.

Detailed description

A total of 40 eyes will be included. 20 eyes with scleral inflammation and 20 eyes from healthy subjects as controls. Each patient will undergo complete ophthalmic and medical examination. Laboratory studies will performed whenever indicated. Optical coherence tomography B-scans of the sclera in the perilimbal area will done for all cases.

Interventions

OTHEROptical Coherence Tomography

Sponsors

The Eye Center and The Eye Foundation for Research in Ophthalmology
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients over the age of 18 years any gender * Patients with clinical signs of scleritis or episcleritis * Signed informed consent

Exclusion criteria

* Infectious keratitis or conjunctivitis * Patients 18 years or younger * Inability to open the eye

Design outcomes

Primary

MeasureTime frameDescription
To describe the optical coherence tomography (OCT) findings in eyes with scleral inflammation3 monthsTo differentiate cases with anterior scleritis from those with episcleritis and normal controls

Countries

Saudi Arabia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026